Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New Hyde Park, New York 11040


Purpose:

The investigators hypothesize that baseline plasma brain natriuretic peptide (BNP) and migration inhibitory factor (MIF) levels are surrogate markers of clinical severity of PAH and that changes in plasma brain natriuretic peptide (BNP) and MIF levels pre and post exercise.


Study summary:

As above


Criteria:

Inclusion Criteria: - Confirmed diagnosis of PAH, based on currently accepted gold standard for Right Heart Catheterization. - Patients with mean artery pressure of greater that 25 mm Hg at rest or 30mm Hg during exercise with pulmonary capillary wedge pressure less than 18mm Hg on right heart catheterization. Exclusion Criteria: - Significant left heart disease or renal insufficiency (serum creatinine > 1.5 mg%).


NCT ID:

NCT00566423


Primary Contact:

Principal Investigator
Arunabh Talwar, MD
North Shore Long Island Jewish Health System


Backup Contact:

N/A


Location Contact:

New Hyde Park, New York 11040
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.